Vnitr Lek 2010, 56(7):669-675

ECG markers in patients with hypertrophic cardiomyopathy

K. Hudecová1,*, I. Šimková2, M. Bernadič1
1 Ústav patologickej fyziológie Lekárskej fakulty UK Bratislava, Slovenská republika, prednosta doc. MUDr. Marián Bernadič, CSc., mim. prof.
2 Kardiologická klinika Slovenskej zdravotníckej univerzity a Národného ústavu srdcových a cievnych chorôb Bratislava, Slovenská republika, prednosta prof. MUDr. Róbert Hatala, CSc.

Background:
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited disease of the heart muscle whose main characteristic is unexplained hypertrophy of the left ventricle and/or right ventricle. It is considered to be the most common genetically determined cardiovascular disease with the prevalence in the population approximately 1 to 500 inhabitants. The disease is associated with severe complications such as heart failure, arrhythmias and sudden cardiac death (SCD). Nowadays the aim of intensive clinical research is to judge the contribution of noninvasive methods in the risk stratification of HCM patients. Abnormal electrocardiogram occurs in 75-95 % and it often presents the first point for HCM suspicion although it is nonspecific.

Aim:
The aim of our study was to evaluate the electrocardiographic (standard 12-lead) and certain echocardiographic markers in patients with recurrent syncope of unknown origin in comparison with patients without these episodes.

Patients and methods:
42 patients (17 men a 25 women) with verified HCM diagnosis underwent extensive clinical, standard 12-lead electrocardiographic and echocardiographic testing to compare these parameters in the subgroup of patients with syncope (n = 17) of unknown origin and patients without syncope (n = 23).

Results:
As for the electrocardiographic signs we found that more than one half of patients had positive Sokolow-Lyon index (55.6%), prolonged QTc interval (63.2%). Depression of ST segment was present in 60.5%. We also found positive correlation between prolonged QTc interval and maximal left ventricle thickness. We observed that patients with syncope had statistically significantly left ventricle end-diasotlic diameter in comparison with patients without syncope.

Conclusion:
Standard electrocardiography represents a "gold standard" in the diagnostics of HCM patients. We found positive correlation between prolonged QTc interval and maximal left ventricle thickness. Patients with syncope had statistically significantly smaller left ventricle end-diastolic diameter in comparison with patients without syncope.

Keywords: hypertrophic cardiomyopathy; ECG; echocardiography; syncope; diagnostics

Received: May 14, 2010; Published: July 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hudecová K, Šimková I, Bernadič M. ECG markers in patients with hypertrophic cardiomyopathy. Vnitr Lek. 2010;56(7):669-675.
Download citation

References

  1. Maron BJ, McKenna WJ, Danielson GK et al. American College of Cardiology/European Society of Cardiology Clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology foundation task force on clinical expert consensus documents and the European Society of Cardiology committee for practise guidelines. Eur Heart J 2003; 24: 1965-1991. Go to original source... Go to PubMed...
  2. Ho CY, Seidman CE. A contemporary approach to hypertrophic cardiomyopathy. Circulation 2006; 113: 858-862. Go to original source...
  3. Kaludercic N, Reggiani C, Paolocci N. Genes, geography an geometry the "critical mass" in hypertrophic cardiomyopathy. J Mol Diagn 2009; 11: 12-16. Go to original source... Go to PubMed...
  4. Ommen SR, Gersh BJ. Sudden cardiac death risk in hypertrophic cardiomyopathy. Eur Heart J 2009; 30: 2558-2559. Go to original source... Go to PubMed...
  5. Elliott PM, Poloniecki J, Dickie S et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol 2000; 36: 2212-2218. Go to original source... Go to PubMed...
  6. Maron BJ. Hypertrophic cardiomyopathy: a systematic Review. JAMA 2002; 287: 1308-1320. Go to original source... Go to PubMed...
  7. Hudecová K, Šimková I, Gardlík R et al. Genetic screening of patients with hypertrophic cardiomyopathy - a new diagnostic strategy in risk stratification? Bratisl Lek Listy 2009; 110: 85-92. Go to PubMed...
  8. Tendera M, Polonski L, Wodniecki J et al. Evolution of the electrocardiographic changes in patients with hypertrophic cardiomyopathy. Clin Cardiol 1991; 14: 891-896. Go to original source... Go to PubMed...
  9. Mattos BP, Torres MA, Freitas VC. Diagnostic evaluation of hypertrophic cardiomyopathy in its clinical and preclinical phases. Arq Bras Cardiol 2008; 91: 51-62. Go to PubMed...
  10. Haghjoo M, Faghfurian B, Taherpour M et al. Predictors of syncope in patients with hypertrophic cardiomyopathy. Pacing Clin Electrophysiol 2009; 32: 642-647. Go to original source... Go to PubMed...
  11. Nienaber CA, Hiller S, Spielmann R et al. Syncope in hypertrophic cardiomyopathy: multivariate analysis of prognostic determinants. J Am Coll Cardiol 1990; 15: 948-955. Go to original source... Go to PubMed...
  12. Schiavone WA, Maloney JD, Lever HM et al. Electrophysiologic studies of patients with hypertrophic cardiomyopathy presenting with syncope of undetermined etiology. Pacing Clin Electrophysiol 1986; 9: 476-481. Go to original source... Go to PubMed...
  13. Dritsas A, Sbarouni E, Gilligan D et al. QT-interval abnormalities in hypertrophic cardiomyopathy. Clin Cardiol 1992; 15: 739-742. Go to original source... Go to PubMed...
  14. Barletta G, Lazzeri C, Franchi F et al. Hypertrophic cardiomyopathy: electrical abnormalities detected by the extended-length ECG and their relation to syncope. Int J Cardiol 2004; 97: 43-48. Go to original source... Go to PubMed...
  15. Yi G, Elliott P, McKenna WJ et al. QT dispersion and risk factors for sudden death in patients with hypertrophic cardiomyopathy. Am J Cardiol 1998; 82: 1514-1519. Go to original source... Go to PubMed...
  16. Göktekin O, Ritsushi K, Matsumoto K et al. The relationship between QT dispersion and risk factors of sudden death in hypertrophic cardiomyopathy. Anadolu Kardiyol Derg 2002; 2: 226-230. Go to PubMed...
  17. Östman-Smith I, Wisten A, Nylander E et al. Electrocardiographic amplitudes: a new risk factor for sudden death in hypertrophic cariomyopathy. Eur Heart J 201; 31: 439-449.
  18. Haghjoo M, Mohammadzadeh S, Taherpour M et al. ST segment depression as a risk factor in hypertrophic caardiomyopathy. Europace 2009; 11: 643-649. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.